Related Experiment Videos
A case of hepatitis related to etretinate therapy and hepatitis B vaccine
1Department of Dermatology, Ninewells Hospital, Dundee, Scotland.
Dermatologica
|January 1, 1991
Abstract:
The case of a 41-year-old male patient is described who developed acute reversible hepatitis related to etretinate therapy. During the course of etretinate he received 2 doses of hepatitis B vaccine; this and his HLA typing A1, A2, Bw57, Cw6 may have predisposed him to develop this reaction.